Elite Pharmaceuticals

About:

Elite Pharmaceuticals develops oral controlled-release products for the pain management, allergy, cardiovascular, and infection areas.

Website: http://www.elitepharma.com

Twitter/X: elitepharma

Top Investors: Lincoln Park Capital Fund, Crede CapitalGroup

Description:

Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tablets, pellets, capsules, granules and powders. The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.

Total Funding Amount:

$7.51M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Northvale, New Jersey, United States

Founded Date:

1996-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2020-07-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai